Preinvasive Cervical Lesions: The Warning Stage Before Cervical Cancer
Preinvasive cervical lesions are abnormal changes in the cells lining the cervix. These changes are not cervical cancer, but some of them may progress to cancer over time if they are not detected, monitored, or treated appropriately.
Most preinvasive cervical lesions do not cause symptoms. They are usually detected during routine cervical screening with a Pap smear, HPV test, colposcopy, or biopsy.
For this reason, a diagnosis of a preinvasive cervical lesion should not be seen only as a frightening result. It is also an important opportunity to prevent cervical cancer before it develops.
What does “preinvasive cervical lesion” mean?
“Preinvasive” means that abnormal cells are limited to the surface layer of the cervix and have not invaded deeper tissues. In other words, this is not invasive cancer.
These lesions may be described using different medical terms, including:
CIN 1: Mild cervical intraepithelial neoplasia
CIN 2: Moderate cervical intraepithelial neoplasia
CIN 3: Severe cervical intraepithelial neoplasia
LSIL: Low-grade squamous intraepithelial lesion
HSIL: High-grade squamous intraepithelial lesion
AIS: Adenocarcinoma in situ, a preinvasive glandular lesion of the cervix
What is the main cause?
The most important cause of preinvasive cervical lesions is persistent infection with high-risk human papillomavirus, known as HPV.
HPV is very common and is usually transmitted through sexual contact. In most people, the immune system clears the infection naturally. However, some high-risk HPV types, especially HPV 16 and HPV 18, can persist in cervical cells and cause cellular changes over time.
Persistent high-risk HPV infection is the key factor in the development of most cervical precancers and cervical cancers.
Does a positive HPV test mean I have cancer?
No. A positive HPV test does not mean that you have cancer. HPV infection is common, and many infections clear on their own.
What matters most is whether the infection persists and whether it has caused significant changes in the cervical cells. Therefore, a positive HPV result should be followed by appropriate evaluation rather than panic.
Do preinvasive cervical lesions cause symptoms?
Usually, no. Most cervical precancers are silent. This is why regular screening is essential.
Some patients may experience symptoms such as:
Bleeding after sexual intercourse
Irregular spotting
Vaginal discharge
Pelvic discomfort
Foul-smelling discharge
However, these symptoms are not specific to cervical precancer. Infections, cervical polyps, hormonal changes, and other gynecological conditions may cause similar complaints.
If I have no symptoms, do I still need screening?
Yes. Because cervical precancers usually do not cause symptoms, screening is one of the most effective ways to prevent cervical cancer.
Pap smears and HPV tests can detect abnormal changes before cancer develops.
How are preinvasive cervical lesions diagnosed?
Diagnosis usually involves several steps.
1. Pap smear
A Pap smear examines cervical cells under a microscope. It can detect abnormal cellular changes. Results may be reported as ASC-US, LSIL, HSIL, or other categories.
2. HPV test
An HPV test checks for high-risk HPV types in the cervix. It is especially important in cervical screening programs for women aged 30 and older, although screening recommendations may vary between countries.
3. Colposcopy
Colposcopy is a detailed examination of the cervix using magnification. Special solutions are applied to the cervix to identify abnormal areas.
4. Biopsy
If a suspicious area is seen during colposcopy, a small tissue sample may be taken. The final diagnosis is usually based on the biopsy result.
Does every abnormal Pap smear require a biopsy?
No. Not every abnormal Pap smear requires immediate biopsy or treatment.
Management depends on several factors, including age, HPV result, Pap smear result, previous screening history, pregnancy status, and colposcopy findings.
Modern guidelines increasingly use a risk-based approach rather than making decisions based on a single test result.
Is treatment always necessary?
Treatment depends mainly on the severity of the lesion.
CIN 1 / low-grade lesions
CIN 1 often represents a temporary HPV-related change. In many patients, especially younger individuals, it may regress spontaneously.
For this reason, observation and regular follow-up are often preferred instead of immediate treatment.
CIN 2 and CIN 3 / high-grade lesions
CIN 2 and CIN 3 represent more significant cell changes. These lesions have a higher risk of progression to cervical cancer, so treatment is commonly recommended.
The treatment decision should consider age, fertility plans, extent of the lesion, colposcopy findings, and pathology results.
What are the treatment options?
The goal of treatment is to remove or destroy abnormal cervical cells and prevent cervical cancer.
LEEP / LLETZ
LEEP, also known as LLETZ, removes the abnormal area using a thin wire loop. It is one of the most commonly used treatments and is usually quick and effective.
Cone biopsy / conization
Conization removes a cone-shaped piece of tissue from the cervix. It may be preferred when the lesion extends into the cervical canal, when the abnormal area cannot be fully seen, or when a more detailed tissue evaluation is needed.
It can be performed using cold knife, laser, or other techniques.
Ablative treatments
In selected cases, abnormal tissue may be destroyed rather than removed. Examples include cryotherapy and laser ablation.
Ablative treatment is suitable only when the entire lesion can be seen and there is no suspicion of invasive disease.
Can treatment affect fertility or pregnancy?
Most patients can become pregnant after treatment. However, procedures that remove cervical tissue may slightly increase the risk of preterm birth or cervical insufficiency, especially if the excision is large or repeated.
For patients who wish to have children in the future, the decision to treat should be carefully individualized. The goal is to avoid unnecessary treatment while also not neglecting high-risk lesions.
Is follow-up necessary after treatment?
Yes. Follow-up is essential even after successful treatment.
HPV infection may persist, and abnormal cells may recur. Follow-up usually includes HPV testing, Pap smear, or both. The first follow-up test is often planned around 6 months after treatment, although the exact timing depends on the individual case and local guidelines.
Patients treated for high-grade lesions usually need long-term surveillance.
Does the HPV vaccine treat existing lesions?
No. The HPV vaccine does not treat an existing HPV infection or an existing cervical lesion.
However, HPV vaccination can help prevent new infections caused by HPV types included in the vaccine. It is most effective when given before exposure to HPV, but some adults may still benefit depending on their individual risk profile.
Vaccination should be discussed with a healthcare professional.
What should patients pay attention to?
Patients diagnosed with preinvasive cervical lesions should keep the following points in mind:
Do not skip follow-up visits.
Stop smoking if applicable.
Discuss HPV vaccination with your doctor.
Inform your doctor about any immune system disorder or immunosuppressive medication.
Mention pregnancy plans before treatment.
Remember that HPV positivity or an abnormal Pap result does not automatically mean cancer.
When should I see a doctor?
A gynecological evaluation is recommended if you have:
An abnormal Pap smear or HPV test
Bleeding after sexual intercourse
Irregular vaginal bleeding
Bleeding after menopause
Persistent or foul-smelling vaginal discharge
A previous diagnosis of CIN 2, CIN 3, or AIS
Missed follow-up after treatment
Conclusion
Preinvasive cervical lesions are important warning signs that can be detected before cervical cancer develops. With regular screening, accurate diagnosis, appropriate treatment, and careful follow-up, cervical cancer is largely preventable.
The most important point is that test results should not be interpreted in isolation. Each patient’s age, HPV status, Pap smear result, biopsy result, fertility plans, and medical history should be considered together.
This text is for informational purposes only. Diagnosis, treatment, and follow-up should be planned by a qualified gynecologist.
